StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.70−0.05 (-6.46%)

Close on Oct 19, 2026Market cap $1.45MP/E –Yield –

Bluejay Diagnostics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bluejay Diagnostics's revenue for the twelve months ending Dec 31, 2022 was $249.04K. For fiscal 2022 it was $249.04K.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$249.04K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$249.04K–

More Bluejay Diagnostics figures

See a number that looks wrong?